Germany· DE-A57-ecd6a4e9fd7a047d
Amlyo
A amsacrine product containing amsacrine, registered in Germany by Eurocept International Bv. The same ATC class is registered in 10 of our 19 countries.
Checked against EMA Article 57 (European Union) on
Informational only — not a medical device.
Where it is registered
Amsacrine is registered in 10 of 19 countries.
Countries holding a registration under ATC L01XX01 (amsacrine), each read from that country’s own register.
- This record: Germany, from EMA Article 57 (European Union)
- 5 of them publish a price we can compare per daily dose
Amsacrine · ATC L01XX01
10 / 19 countries
- Belgiumprice
- Denmark
- Finlandprice
- Franceprice
- Germany
- Icelandprice
- Ireland
- Netherlands
- Norwayprice
- United Kingdom
The record
At a glance
EMA Article 57 (European Union)- Active substance
- Amsacrine
- Manufacturer
- Eurocept International Bv
- Country
- Germany (DE)
- ATC code
- L01XX01
- ATC class
- Amsacrine
- Reimbursed
- Not published by this register
- Source register
- EMA Article 57 (European Union)
- Last checked
- September 30, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Amsacrine in 10 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- FinlandAmekrinPfizer Oy
- United KingdomAmsidine 75mg/1.5ml concentrate and solvent for solution for infusion vialsEurocept International bv
- NorwayAmlyoEurocept
- FranceAMSALYO 75 mg, poudre pour solution pour perfusionEUROCEPT INTERNATIONAL (PAYS-BAS)
- IrelandAmsalyo 75 mg powder for concentration for solution infusionEurocept International BV
- IcelandAmsalyoEurocept International B.V.
- NetherlandsAmsalyo 75 mg poeder voor concentraat voor oplossing voor infusieEurocept International B.V.
- BelgiumAmsidine 75 mg/1.5 mlEurocept International
Authorised across Europe · EMA
The same active substance is authorised in 12 EEA countries. Names it is sold under:
- Austria · Amlyo
- Denmark · Amsalyo
- Finland · Amsalyo
- France · Amsalyo
- Croatia · Amlyo
- Ireland · Amsalyo
- Iceland · Amsalyo
- Italy · Amsalyo
- Luxembourg · Amsalyo
- Netherlands · Amsalyo
- Norway · Amsalyo
- Sweden · Amsalyo
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of EMA Article 57 (European Union). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/65a01085-a42b-48fc-805c-0321576283a8 GET /v1/drugs/65a01085-a42b-48fc-805c-0321576283a8?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"pzn": null,
"route": "Intravenous Use",
"source": "ema_art57_de",
"ma_number": null,
"substance": "Amsacrine",
"atc_from_source": null,
"authorisation_country": "Germany"
}See everything about amsacrine.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.